GN Store Nord
Health Care Equipment
Denmark
ESRS disclosure: ESRS S4 \ DR S4-4 \ Paragraph AR 27
Tags Tree
Selected: 0
No matching results found.
- Does the undertaking disclose the process for setting targets related to managing material negative impacts, advancing positive impacts, and managing material risks and opportunities? Specifically, does it detail whether and how the undertaking engaged directly with consumers and/or end-users, their legitimate representatives, or credible proxies with insight into their situation? Furthermore, given that material negative impacts affecting consumers and/or end-users during the reporting period may be linked to entities or operations outside the undertaking's direct control, does the undertaking disclose whether and how it seeks to use leverage with relevant business relationships to manage those impacts? This may include the use of commercial leverage, such as enforcing contractual requirements or implementing incentives, other forms of leverage within the relationship, such as providing training or capacity-building on proper product use or sale practices, or collaborative leverage with peers or other actors, such as initiatives aimed at responsible marketing or product safety.
-
Question Id: S4-4_13
GN has implemented several policies, actions, and targets for managing product safety and data privacy related risks. As data privacy and product safety are strictly regulated by international and local laws, targets are mainly determined based on these regulations. Given the compliance-based nature of IROs, GN has not directly engaged with consumers and end-users when setting targets, tracking performance, or when identifying lessons learnt.
Report Date: 4Q2024Relevance: 40%